(Q33703566)

English

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

0 references

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States (English)

1 reference

Europe PubMed Central

28 July 2017

3

object named as

L Joseph Wheat

1 reference

Europe PubMed Central

28 July 2017

Lindsey R Baden

6

object named as

Lindsey R Baden

1 reference

Europe PubMed Central

28 July 2017

17

object named as

Thomas J Walsh

1 reference

Europe PubMed Central

28 July 2017

Angela Caliendo

5

object named as

Angela M Caliendo

1 reference

Europe PubMed Central

28 July 2017

author name string

Paschalis Vergidis

1

1 reference

Europe PubMed Central

28 July 2017

Raymund R Razonable

2

1 reference

Europe PubMed Central

28 July 2017

Lynn Estes

4

1 reference

Europe PubMed Central

28 July 2017

John R Wingard

7

1 reference

Europe PubMed Central

28 July 2017

John Baddley

8

1 reference

Europe PubMed Central

28 July 2017

Maha Assi

9

1 reference

Europe PubMed Central

28 July 2017

Steven Norris

10

1 reference

Europe PubMed Central

28 July 2017

Pranatharthi Chandrasekar

11

1 reference

Europe PubMed Central

28 July 2017

Ryan Shields

12

1 reference

Europe PubMed Central

28 July 2017

Hong Nguyen

13

1 reference

Europe PubMed Central

28 July 2017

Alison Freifeld

14

1 reference

Europe PubMed Central

28 July 2017

Richard Kohler

15

1 reference

Europe PubMed Central

28 July 2017

Martin Kleiman

16

1 reference

Europe PubMed Central

28 July 2017

Chadi A Hage

18

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

9 April 2014

1 reference

Europe PubMed Central

28 July 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

28 July 2017

52

1 reference

Europe PubMed Central

28 July 2017

6

1 reference

Europe PubMed Central

28 July 2017

2199-2201

1 reference

Europe PubMed Central

28 July 2017

Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

21 June 2018

Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

21 June 2018

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

21 June 2018

The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

30 October 2018

Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

30 October 2018

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

30 October 2018

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

30 October 2018

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4042793

30 October 2018

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/24719434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

False positive galactomannan Platelia due to piperacillin-tazobactam

1 reference

https://pubmed.ncbi.nlm.nih.gov/24719434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/24719434

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.00285-14

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33703566&oldid=1915391469"